Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Cardiff Oncology (CRDF) over the last 8 years, with Q3 2025 value amounting to $716000.0.

  • Cardiff Oncology's Interest & Investment Income fell 337.38% to $716000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 577.59%. This contributed to the annual value of $3.3 million for FY2024, which is 1990.66% down from last year.
  • As of Q3 2025, Cardiff Oncology's Interest & Investment Income stood at $716000.0, which was down 337.38% from $835000.0 recorded in Q2 2025.
  • Cardiff Oncology's Interest & Investment Income's 5-year high stood at $1.1 million during Q3 2023, with a 5-year trough of $716000.0 in Q3 2025.
  • Moreover, its 3-year median value for Interest & Investment Income was $880500.0 (2024), whereas its average is $888000.0.
  • As far as peak fluctuations go, Cardiff Oncology's Interest & Investment Income plummeted by 3061.8% in 2024, and later skyrocketed by 372.67% in 2025.
  • Over the past 3 years, Cardiff Oncology's Interest & Investment Income (Quarter) stood at $1.0 million in 2023, then dropped by 21.92% to $787000.0 in 2024, then decreased by 9.02% to $716000.0 in 2025.
  • Its Interest & Investment Income stands at $716000.0 for Q3 2025, versus $835000.0 for Q2 2025 and $941000.0 for Q1 2025.